September 2024

Quarterly

Quarterly Report: Quarter 4, FY 2024
The OIG published its fourth quarterly report for fiscal year 2024, summarizing the agency’s work and results achieved between June 1, 2024, and August 31, 2024.

Audit

EEG Services in Texas Medicaid: Texas Children’s Physician Group
The audit objective was to determine whether claims submitted by Texas Children’s for ambulatory electroencephalogram (EEG) tests followed selected Texas Medicaid Provider Procedures Manual guidelines. Issued September 26, 2024. OIG Report No. AUD-25-003.

August 2024

Audit

Rolling Audit and Inspections Plan 2025
The OIG has updated its Rolling Audit and Inspections Plan, which outlines potential audit and inspections areas and topics.The OIG Audit and Inspections Division conducts a continuous risk assessment to identify potential topics for inclusion in its Rolling Audit and Inspections Plan. Potential audit and inspections topics consist of programs, services, providers and contractors with an elevated potential for fraud, waste and abuse.

Audit

National Seating & Mobility
The OIG Audit and Inspections Division contracted Myers and Stauffer LC to determine whether paid MCO DME claims billed to, and paid under, the state Medicaid program were in accordance with applicable state and federal Medicaid laws, regulations, rules, policies and contractual requirements. Issued August 29, 2024. OIG Report No. AUD-24-032.

Audit

Managed Care Pharmacy Encounters Paid to Omnicare Pharmacy
Executive Summary - The audit objective was to determine whether Omnicare Pharmacy (a) properly dispensed prescriptions associated with selected encounters for Texas Medicaid members enrolled with Superior HealthPlan, Inc., UnitedHealthcare Community Plan of Texas, L.L.C., and UnitedHealthcare Insurance Company, Inc., and (b) complied with applicable contractual, state, and federal requirements. Issued August 28, 2024. OIG Report No. AUD-24-029.

Audit

Managed Care Pharmacy Encounters Paid to Meadowbrook Pharmacy
Executive Summary - The audit objective was to determine whether Meadowbrook Pharmacy (a) properly dispensed prescriptions associated with selected encounters for Texas Medicaid and CHIP members enrolled with Cook Children’s Health Plan, Wellpoint Texas, Inc., and Wellpoint Insurance Company and (b) complied with applicable contractual, state, and federal requirements. Issued August 23, 2024. OIG Report No. AUD-24-027.